Global B2B Pharmaceutical Sourcing · Dossier Licensing · Named-Patient Access
💬 WhatsApp · Sign in · Register
Glycopyrrolate + Indacaterol bulk supplier for pharma manufacturers

Glycopyrrolate + Indacaterol Suppliers & Bulk Manufacturers

Available Forms: Inhalation powder, hard capsules

Available Strengths: 110/50 mcg per capsule (delivers indacaterol 85 mcg + glycopyrronium 43 mcg)

Reference Brands: Utibron Neohaler(Dis.cntd in US-2020); Ultibro Breezhaler(EU)

Category: Respiratory Disorder

Indacaterol and glycopyrronium inhalation powder in capsules with a dry powder inhaler, a once-daily LABA and LAMA combination for COPD maintenance. For respiratory distributors, hospitals and importers.

Get Enquiry / Request Bulk Quote

Usually answered within 48 hours | GMP documents shared before you commit

Manufacture or export Glycopyrrolate + Indacaterol? List it or send an offer →

Product Description:

This inhaled combination joins indacaterol, a long-acting beta-2 agonist (LABA), with glycopyrronium, a long-acting muscarinic antagonist (LAMA). One relaxes airway smooth muscle through beta-2 receptors, the other blocks the acetylcholine signal that tightens it. The powder sits in hard capsules, each delivering indacaterol 85 micrograms and glycopyrronium 43 micrograms. The patient loads one capsule into a single-dose dry powder inhaler, pierces it and inhales; the device is part of the product and comes in each pack.

It is a once-daily maintenance bronchodilator for adults with chronic obstructive pulmonary disease. It is not a reliever, nor for asthma, where a LABA must never be given without an inhaled corticosteroid. Capsules are for inhalation only; swallowing them is a common error worth stressing in counselling. Cautions include unstable heart disease, prolonged QT, narrow-angle glaucoma, urinary retention and severe renal impairment. Paradoxical bronchospasm calls for stopping it at once. Inhaler technique checks belong in every review.

Sourcing notes. Capsules stay in their blister until the moment of use, because moisture and light degrade the powder, so blister quality and device integrity are central to stability. A CoA per batch should cover delivered dose uniformity and aerodynamic particle size distribution, not only assay. Generic inhalation products need more than standard bioequivalence, often in vitro device comparison plus pharmacokinetic or clinical data, so ask what the dossier contains. Request the GMP certificate, a CoPP and zone IVb stability data. State capsules per pack, inhaler included or not, and language.

Glycopyrrolate + Indacaterol — third party manufacturing & bulk supply

Glycopyrrolate + Indacaterol is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.
Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.
Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Glycopyrrolate + Indacaterol is supplied as Inhalation powder, hard capsules — supplied in more than one dosage form, each with its own manufacturing economics, so the indicative MOQ is a minimum order value of USD 5,000 per product. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Glycopyrrolate + Indacaterol listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Glycopyrrolate + Indacaterol →

Usually answered within 48 hours, with matched manufacturers, indicative prices and document status.

Back to Listing

Frequently Asked Questions

Glycopyrrolate + Indacaterol is listed as Inhalation powder, hard capsules in 110/50 mcg per capsule (delivers indacaterol 85 mcg + glycopyrronium 43 mcg). Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Glycopyrrolate + Indacaterol is referenced against Utibron Neohaler(Dis.cntd in US-2020); Ultibro Breezhaler(EU). Reference brands are shown for identification only and remain the property of their respective trademark owners.

Related Products

Doxofylline Tablet

Strength:
200 mg, 400 mg

Form: Tablet

Reference Brands: -

View Details
Glycopyrrolate / Formoterol

Strength:
Glycopyrrolate 9 mcg + Formoterol fumarate 4.8 mcg

Form: Pressurized metered-dose inhaler (pMDI)

Reference Brands: Bevespi Aerosphere(US)

View Details
Ethofylline & Theophylline Injection

Strength:
84.7 mg Ethofylline + 25.3 mg Theophylline

Form: Injection

Reference Brands: Deriphyllin®

View Details
Oxtriphylline(Choline Theophyllinate)

Strength:
200 mg, 400 mg, and 600 mg

Form: Tablets

Reference Brands: Choledyl

View Details
Oxomemazine

Strength:
0.33 mg/mL, 1.65 mg, 2.5 mg

Form: Syrup/ Tablet

Reference Brands: -

View Details
Aminophylline Injection

Strength:
25 mg/mL,

Form: Injection/ Infusion

Reference Brands: -

View Details
Cloperastine

Strength:
3.54 mg/mL, 10mg

Form: Syrup/ Tablet

Reference Brands: Flutox (EU)

View Details
Guaifenesin

Strength:
600mg, 1200mg, 100 mg/5 mL

Form: Tablets / Capsules / Syrup

Reference Brands: Mucinex (USA), Robitussin (USA)

View Details
Enquire Now

Usually answered within 48 hours | GMP documents shared before you commit

Subscribe to Our Newsletter

Stay updated on pharma trends and sourcing opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.
WhatsApp us